Metacognitions, anxiety, and distress related to motor fluctuations in Parkinson's disease
Introduction
Parkinson's disease (PD) is a progressive neurological disorder with an estimated population prevalence of approximately 300 per 100,000, increasing to 1%, over the age of 60 years and up to 4% in the oldest age groups [1]. PD is typically considered a disorder of movement with symptoms of slowed and reduced amplitude voluntary action, tremor, and rigidity affecting limb and eye movement, in addition impaired control of balance, swallowing, and speech. A range of disabling non-motor symptoms are also commonly experienced including depression, anxiety, psychosis, cognitive impairment, autonomic dysfunction, fatigue, and pain. Motor and non-motor disability increase with disease progression despite symptomatic treatment using levodopa, dopamine agonists, or other drugs that modify brain dopamine levels. With disease progression and increasing duration of treatment, effectiveness gradually declines. In those treated with levodopa, fluctuations in symptom severity over the course of the day commonly develop. These include ‘wearing off’ (a relatively predictable re-emergence of symptoms towards the end of a medication dose); ‘on/off fluctuations’ (unpredictable and sudden recurrence of Parkinsonian symptoms); ‘delayed on’ (unpredictably increased time between ingestion of a dose and motor benefit), and ‘dose failure’ (unpredictable failure of a dose to provide usual benefit) [2]. In addition to worsening of motor symptoms during ‘off-periods’, the emergence or exacerbation of distressing non-motor symptoms is also reported by many individuals including pain, fatigue, drenching sweats, depression, and anxiety.
Currently, fluctuations and associated symptoms are managed by alterations in drug regimen but this becomes increasingly difficult with disease progression. This offers potential to develop adjunctive psychological approaches to manage individual symptoms (e.g. depressed mood, pain, or fatigue) or reduce the level of associated subjective distress. There is evidence that traditional CBT treatment approaches can be helpful in reducing depressive and anxiety symptoms in PD [3], [4] although not specifically in the context of motor fluctuations. One challenge of CBT is the limits on reality-testing of thoughts and beliefs about PD (e.g. ‘there is no cure for this disease’ or ‘I have no control over my symptoms’) as these may represent accurate appraisals of the disease, and may be challenging to test during ‘in the moment’ distress associated with off-periods. Key to developing a more targeted therapy is an understanding of the cognitive and attentional processes that contribute to the emotional difficulties experienced by some with PD including those associated with off-period distress. We propose that metacognitive therapy (MCT) [5], an effective treatment for depression and anxiety [6] may be particularly well-suited to the management of PD distress. MCT is based on the Self-Regulatory Executive Function model (S-REF) [7] and posits that psychological distress results from perseverative cognitive processes (e.g. rumination and worry) and attentional strategies (e.g. symptom focussing and hypervigilance). These are proposed to be governed by both explicit and implicit metacognitions and form a Cognitive Attentional Syndrome (CAS). Preliminary research has implicated metacognitions in distress in a small sample of people with PD [8]. S-REF proposes that specific CAS configurations are activated in response to inner events such as cognitions (including memories), emotions, and physical states. If an individual with PD experiences symptoms associated with an off-period and endorses positive metabeliefs about worry (e.g. “worry helps me to solve problems”), the response to this off-related symptom will be worry. An individual who holds negative beliefs about worry, such as ‘my worry is uncontrollable’, may be less inclined to make attempts to halt this cognitive process and instead to ‘worry about worry’, increasing distress further and helping to drive more worry. In both instances a stop-signal for this process is not received (i.e. the goal of solving a problem), resulting in worry perseveration and distress. The modifications of the metacognitions that are hypothesized to fuel maladaptive CAS configurations are a key target of MCT interventions.
In this study, we test the following hypothesis: that metacognitive factors explain a significant proportion of variance in anxiety and off-period distress after controlling for disease characteristics, cognitive function, off-period predictability, and trait intolerance of uncertainty.
Section snippets
Participants and procedure
Participants with a clinical diagnosis of PD were recruited from a cohort of patients involved in a separate longitudinal study (n = 512), PROMS-PD [9]. We approached individuals that had expressed a willingness to engage with additional research, who were judged at their last assessment to have capacity to consent, and had sufficient sensory and motor function to complete a booklet of questionnaires. Those who had been seen for assessment for the main study in the past three months or due to
Acknowledgements
The authors acknowledge the members of the PROMS-PD Study Group who were responsible for the cohort from which the study participants were recruited.
London
KR Chaudhuri, King's College Hospital NHS Foundation Trust, London (participant recruitment)
C Clough, King's College Hospital NHS Foundation Trust, London (participant recruitment)
B Gorelick, Parkinson's Disease Society, London (member of the study management group)
A Simpson, Institute of Psychiatry, King's College London, London (data
References (23)
- et al.
Epidemiology of Parkinson's disease
Lancet Neurol
(2006) - et al.
The intolerance of uncertainty scale: psychometric properties of the English version
Behav Res Ther
(2002) - et al.
Beliefs about worry and intrusions: the meta-cognitions questionnaire and its correlates
J Anxiety Disord
(1997) - et al.
Measuring metacognitions associated with emotional distress: factor structure and predictive validity of the metacognitions questionnaire 30
Personal Individ Differ
(2008) - et al.
Metacognitions and negative emotions as predictors of symptom severity in chronic fatigue syndrome
J Psychosom Res
(2011) - et al.
The impact and management of nonmotor symptoms of Parkinson's disease
Am J Manag Care
(2011) - et al.
The role of cognitive–behavioural therapy for patients with depression in Parkinson's disease
Parkinsons Dis
(2011) - et al.
Cognitive–behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial
Am J Psychiatry
(2011) Metacognitive therapy for anxiety and depression
(2008)- et al.
The efficacy of metacognitive therapy for anxiety and depression: a meta-analytic review
Depress Anxiety
(2014)
Attention and emotion: a clinical perspective
Cited by (35)
The psychological correlates of fatigue in Parkinson's disease: Contribution of maladaptive metacognitive beliefs
2021, Parkinsonism and Related DisordersCitation Excerpt :To date, the few studies assessing the efficacy of nonpharmacologic interventions in fatigue in PD have used graded exercise, energy management strategy, or standard Cognitive Behavioural Therapy (CBT) approaches and have reported mixed findings [7]. Nevertheless, these approaches may be limited by the motor impairments and difficulties with disputing the validity of some thoughts about disease such as ‘there is no cure for PD’ [9], respectively. Interventions aimed at modifying maladaptive metacognitive beliefs (i.e., Metacognitive Therapy; Ref. 8) do not require to challenge the truth of thoughts related to valid appraisals of disease course and are not limited by the motor impairments [9].
Testing relationships between metacognitive beliefs, anxiety and depression in cardiac and cancer patients: Are they transdiagnostic?
2019, Journal of Psychosomatic ResearchTolerance of uncertainty: A systematic review of health and healthcare-related outcomes
2018, Patient Education and CounselingThe contribution of illness perceptions and metacognitive beliefs to anxiety and depression in adults with diabetes
2018, Diabetes Research and Clinical Practice